de Porto, A. P., Liu, Z., de Beer, R., Florquin, S., de Boer, O. J., Hendriks, R. W., . . . de Vos, A. F. (2019). Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia. Molecular medicine (Cambridge, Mass.), 25(1), 3-10. https://doi.org/10.1186/s10020-018-0069-7
Chicago-Zitierstil (17. Ausg.)de Porto, Alexander P., Zhe Liu, Regina de Beer, Sandrine Florquin, Onno J. de Boer, Rudi W. Hendriks, Tom van der Poll, und Alex F. de Vos. "Btk Inhibitor Ibrutinib Reduces Inflammatory Myeloid Cell Responses in the Lung During Murine Pneumococcal Pneumonia." Molecular Medicine (Cambridge, Mass.) 25, no. 1 (2019): 3-10. https://doi.org/10.1186/s10020-018-0069-7.
MLA-Zitierstil (9. Ausg.)de Porto, Alexander P., et al. "Btk Inhibitor Ibrutinib Reduces Inflammatory Myeloid Cell Responses in the Lung During Murine Pneumococcal Pneumonia." Molecular Medicine (Cambridge, Mass.), vol. 25, no. 1, 2019, pp. 3-10, https://doi.org/10.1186/s10020-018-0069-7.